Fund moves

Harmony Biosciences Holdings, Inc. (HRMY)Bridgewater Associates added to its stake +17K shares

Bridgewater Associates added to its stake in Harmony Biosciences Holdings, Inc., per its Q4 2025 13F.

229K
Shares reported · +17K vs prior quarter
0.03%
Disclosed portfolio weight
$8.55M
Reported value
Holdings as of
Dec 31, 2025
Filed
Feb 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

What came next

  1. Feb 24, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Mar 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 2, 2026, Harmony Biosciences Holdings, Inc. (the “Company”) named Peter Anastasiou the Company’s Senior Executive Vice President and Chief Operating Officer (“COO”), effective April 2, 2026.”
  3. Apr 14, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 14, 2026, Harmony Biosciences Holdings, Inc. (the “Company”) announced that Sandip Kapadia, the Company’s Chief Financial Officer, will be stepping down as the Company’s Chief Financial Officer effective as of April 14, 2026 to pursue other career opportunities.”
  4. May 7, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Harmony Biosciences Holdings, Inc.

For Harmony Biosciences Holdings, Inc., OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HRMY page.

How this filing works

Other disclosures at Harmony Biosciences Holdings, Inc.

Everything OQRO holds on this company is on its HRMY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data